These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28238284)

  • 21. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
    Graham-Brown MP; March DS; Churchward DR; Stensel DJ; Singh A; Arnold R; Burton JO; McCann GP
    Kidney Int; 2016 Oct; 90(4):835-44. PubMed ID: 27633869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
    Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
    Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping.
    Bulluck H; Hammond-Haley M; Fontana M; Knight DS; Sirker A; Herrey AS; Manisty C; Kellman P; Moon JC; Hausenloy DJ
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):57. PubMed ID: 28764773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy.
    Xu Y; Sun J; Wan K; Yu L; Wang J; Li W; Yang F; Sun J; Cheng W; Mui D; Zhang Q; Xie Q; Chen Y
    J Cardiovasc Magn Reson; 2020 Apr; 22(1):22. PubMed ID: 32272936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular global myocardial strain assessment comparing the reproducibility of four commercially available CMR-feature tracking algorithms.
    Barreiro-Pérez M; Curione D; Symons R; Claus P; Voigt JU; Bogaert J
    Eur Radiol; 2018 Dec; 28(12):5137-5147. PubMed ID: 29872912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.
    Piechnik SK; Ferreira VM; Lewandowski AJ; Ntusi NA; Banerjee R; Holloway C; Hofman MB; Sado DM; Maestrini V; White SK; Lazdam M; Karamitsos T; Moon JC; Neubauer S; Leeson P; Robson MD
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):13. PubMed ID: 23331520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients.
    Qin L; Gu S; Xiao R; Liu P; Yan F; Yu H; Yang W
    Eur Radiol; 2022 Oct; 32(10):6878-6890. PubMed ID: 35554644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-contrast myocardial T1 global and regional reference values at 3 Tesla cardiac magnetic resonance in aortic stenosis.
    Elbaum C; Iacuzio L; Bohbot Y; Civaia F; Dommerc C; Tribouilloy C; Guerin P; Levy F
    Arch Cardiovasc Dis; 2021 Apr; 114(4):293-304. PubMed ID: 33716045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance.
    Graham-Brown MP; Singh AS; Gulsin GS; Levelt E; Arnold JA; Stensel DJ; Burton JO; McCann GP
    BMC Cardiovasc Disord; 2018 Jul; 18(1):145. PubMed ID: 30005636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Ventricular Vertical Run-Length Nonuniformity MRI Adds Prognostic Value to MACE in Patients with End-Stage Renal Disease.
    Zhang TY; An DA; Zhou H; Chen B; Lu R; Fang W; Wang Q; Huang J; Jin H; Shen J; Zhou Y; Hu J; Bautista M; Ouchi T; Wu LM; Mou S
    J Magn Reson Imaging; 2024 Feb; 59(2):522-532. PubMed ID: 37203257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
    Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping.
    Haslbauer JD; Lindner S; Valbuena-Lopez S; Zainal H; Zhou H; D'Angelo T; Pathan F; Arendt CA; Bug G; Serve H; Vogl TJ; Zeiher AM; Carr-White G; Nagel E; Puntmann VO
    Int J Cardiol; 2019 Jan; 275():179-186. PubMed ID: 30360992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
    Pica S; Sado DM; Maestrini V; Fontana M; White SK; Treibel T; Captur G; Anderson S; Piechnik SK; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Kellman P; Elliott PM; Herrey AS; Moon JC
    J Cardiovasc Magn Reson; 2014 Dec; 16(1):99. PubMed ID: 25475749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.
    Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.